Prescribing Buprenorphine for Opioid Use Disorders in the ED: A Review of Best Practices, Barriers, and Future Directions

References

• National Center for Health Statistics. Provisional Drug Overdose Death Counts 2019. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
   Google Scholar
• Bose J, Hedden S, Lipari R, Park-Lee E. Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017.
   Google Scholar
• Agency for Healthcare Research and Quality. Health Care Costs and Utilization Project 2020. www.hcup-us.ahrq.gov/home.jsp. Accessed September 21, 2020.
   Google Scholar
• American Psychiatric Assocation. Substance-related and addictive disorders. Diagnostic and Statistical Manual of Mental Disorders. 5th. Washingston. 2013.
   Google Scholar
• National Institute of Drug Abuse. Substance Use Screen/Adapted NM Assist Tool:2015. https://www.drugabuse.gov/nidamed-medical-health-professionals/screening-tools-resources/american-psychiatric-association-adapted-nida-modified-assist-tools. Accessed May 13, 2020.
   Google Scholar
• Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432–442. doi:10.1111/j.1526-4637.2005.00072.x
   PubMed Web of Science ®Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;2009(3):Cd002209.
   PubMedGoogle Scholar
• Russolillo A, Moniruzzaman A, Somers JM. Methadone maintenance treatment and mortality in people with criminal convictions: A population-based retrospective cohort study from Canada. PLoS Med. 2018;15(7):e1002625. doi:10.1371/journal.pmed.1002625
   PubMed Web of Science ®Google Scholar
• Farmani F, Farhadi H, Mohammadi Y. Associated Factors of Maintenance in Patients under Treatment with Methadone: A Comprehensive Systematic Review and Meta-Analysis. Addict Health. 2018;10(1):41–51.
   Google Scholar
• Maremmani AGI, Pacini M, Maremmani I. What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients. Int J Environ Res Public Health. 2019;16(3):3. doi:10.3390/ijerph16030447
   Web of Science ®Google Scholar
• Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N. Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database Syst Rev. 2016;(5):Cd011117.
   PubMed Web of Science ®Google Scholar
• Sharma B, Bruner A, Barnett G, Fishman M. Opioid Use Disorders. Child and Adolescent Psychiatric Clinics of North America. 2016;25(3):473–487. doi:10.1016/j.chc.2016.03.002
   PubMed Web of Science ®Google Scholar
• D’Onofrio G, O’Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636–1644. doi:10.1001/jama.2015.3474
   PubMed Web of Science ®Google Scholar
• D’Onofrio G, Edelman EJ, Hawk KF, et al. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH). Implement Sci. 2019;14(1):48. doi:10.1186/s13012-019-0891-5
   Web of Science ®Google Scholar
• Higgins J, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane. 2019;2:125.
   Google Scholar
• Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing Quality of Nonrandomised Studies in Meta-Analyses. Ottawa Hospital Res Inst. 2013;23:2154.
   Google Scholar
• McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276–282. doi:10.11613/BM.2012.031
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Dunkley CA, Carpenter JE, Murray BP, et al. Retrospective Review of a Novel Approach to Buprenorphine Induction in the Emergency Department. J Emerg Med. 2019;57(2):181–186. doi:10.1016/j.jemermed.2019.03.029
   PubMed Web of Science ®Google Scholar
• Kaucher KA, Caruso EH, Sungar G, et al. Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program. Am J Emerg Med. 2020;38(2):300–304. doi:10.1016/j.ajem.2019.158373
   PubMed Web of Science ®Google Scholar
• Srivastava A, Kahan M, Njoroge I, Sommer LZ. Buprenorphine in the emergency department: randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal. Can Fam Physician. 2019;65(5): e214-e220.
   Web of Science ®Google Scholar
• Bogan C, Jennings L, Haynes L, et al. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state. J Subst Abuse Treat. 2020;112s:73–78. doi:10.1016/j.jsat.2020.02.007
   PubMed Web of Science ®Google Scholar
• Reuter Q, Smith G, McKinnon J, Varley J, Jouriles N, Seaberg D. Successful Medication-Assisted Treatment Program at a Community Emergency Department. Ann Emerg Med. 2019;74(4):S89. doi:10.1016/j.annemergmed.2019.08.393
   Web of Science ®Google Scholar
• Busch SH, Fiellin DA, Chawarski MC, et al. Cost-effectiveness of emergency department-initiated treatment for opioid dependence. Addiction. 2017;112(11):2002–2010. doi:10.1111/add.13900
   PubMed Web of Science ®Google Scholar
• D’Onofrio G, Chawarski MC, O’Connor PG, et al. Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: outcomes During and After Intervention. J Gen Intern Med. 2017;32(6):660–666. doi:10.1007/s11606-017-3993-2
   PubMed Web of Science ®Google Scholar
• American College of Emergency Physicians. Buprenorphine Use in the Emergency Department Tool. ; 2018. https://www.acep.org/bupe
   Google Scholar
• Melnick ER, Jeffery MM, Dziura JD, et al. User-centred clinical decision support to implement emergency department-initiated buprenorphine for opioid use disorder: protocol for the pragmatic group randomised EMBED trial. BMJ Open. 2019;9(5):e028488. doi:10.1136/bmjopen-2018-028488
   Web of Science ®Google Scholar
• Noormohammadi A, Forinash A, Yancey A, Crannage E, Campbell K, Shyken J. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy. Ann Pharmacother. 2016;50(8):666–672. doi:10.1177/1060028016648367
   PubMed Web of Science ®Google Scholar
• Kelly T, Hoppe JA, Zuckerman M, Khoshnoud A, Sholl B, Heard K. A novel social work approach to emergency department buprenorphine induction and warm hand-off to community providers. Am J Emerg Med. 2020;38(6):1286–1290. doi:10.1016/j.ajem.2019.12.038
   PubMed Web of Science ®Google Scholar
• Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35(2):253–259. doi:10.1080/02791072.2003.10400007
   PubMed Web of Science ®Google Scholar
• Cisewski DH, Santos C, Koyfman A, Long B. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting. Am J Emerg Med. 2019;37(1):143–150. doi:10.1016/j.ajem.2018.10.013
   PubMed Web of Science ®Google Scholar
• Duber HC, Barata IA, Cioe-Pena E, et al. Identification, Management, and Transition of Care for Patients With Opioid Use Disorder in the Emergency Department. Ann Emerg Med. 2018;72(4):420–431. doi:10.1016/j.annemergmed.2018.04.007
   PubMed Web of Science ®Google Scholar
• Jaeger S Jr, Fuehrlein B. Buprenorphine initiation to treat opioid use disorder in emergency rooms. J Neurol Sci. 2020;411:116716. doi:10.1016/j.jns.2020.116716
   Web of Science ®Google Scholar
• Herring AA, Perrone J, Nelson LS. Managing Opioid Withdrawal in the Emergency Department With Buprenorphine. Ann Emerg Med. 2019;73(5):481–487. doi:10.1016/j.annemergmed.2018.11.032
   PubMed Web of Science ®Google Scholar
• Carroll GG, Wasserman DD, Shah AA, et al. Buprenorphine Field Initiation of ReScue Treatment by Emergency Medical Services (Bupe FIRST EMS): A Case Series. Prehosp Emerg Care. 2020;1–6.
   Web of Science ®Google Scholar
• Rosenblatt RA, Andrilla CHA, Catlin M, Larson EH. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med. 2015;13(1):23–26. doi:10.1370/afm.1735
   PubMed Web of Science ®Google Scholar
• Dwyer K, Walley AY, Langlois BK, et al. Opioid education and nasal naloxone rescue kits in the emergency department. West J Emerg Med. 2015;16(3):381–384. doi:10.5811/westjem.2015.2.24909
   PubMed Web of Science ®Google Scholar
• Gunn AH, Smothers ZPW, Schramm-Sapyta N, Freiermuth CE, MacEachern M, Muzyk AJ. The Emergency Department as an Opportunity for Naloxone Distribution. West J Emerg Med. 2018;19(6):1036–1042. doi:10.5811/westjem.2018.8.38829
   PubMed Web of Science ®Google Scholar
• Ahmed OM, Mao JA, Holt SR, et al. A scalable, automated warm handoff from the emergency department to community sites offering continued medication for opioid use disorder: lessons learned from the EMBED trial stakeholders. J Subst Abuse Treat. 2019;102:47–52. doi:10.1016/j.jsat.2019.05.006
   PubMed Web of Science ®Google Scholar
• Sholl B, Heard K, Hoppe J, Capp R, Khoshnoud A, Holland C. Emergency department initiation of buprenorphine/naloxone with warm handoff to community care. Acad Emerg Med. 2019;26:S131.
   Google Scholar
• Kawasaki S, Francis E, Mills S, Buchberger G, Hogentogler R, Kraschnewski J. Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania. J Subst Abuse Treat. 2019;106:58–64. doi:10.1016/j.jsat.2019.08.016
   PubMed Web of Science ®Google Scholar
• Berg ML, Idrees U, Ding R, Nesbit SA, Liang HK, McCarthy ML. Evaluation of the use of buprenorphine for opioid withdrawal in an emergency department. Drug Alcohol Depend. 2007;86(2):239–244. doi:10.1016/j.drugalcdep.2006.06.014
   Web of Science ®Google Scholar
• Jarvis BP, Holtyn AF, Subramaniam S, et al. Extended-release injectable naltrexone for opioid use disorder: a systematic review. Addiction. 2018;113(7):1188–1209. doi:10.1111/add.14180
   PubMed Web of Science ®Google Scholar
• Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev. 2011;2011(4):Cd001333.
   Google Scholar
• Donoghue K, Elzerbi C, Saunders R, Whittington C, Pilling S, Drummond C. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis. Addiction. 2015;110(6):920–930. doi:10.1111/add.12875
   PubMed Web of Science ®Google Scholar
• Camenga DR, Colon-Rivera HA, Muvvala SB. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks. J Stud Alcohol Drugs. 2019;80(4):393–402. doi:10.15288/jsad.2019.80.393
   PubMed Web of Science ®Google Scholar
• Hawk K, McCormack R, Edelman EJ, et al. 260 Perceptions and Experiences of Emergency Department Patients With Opioid Use Disorder. Ann Emerg Med. 2019;74(4):S102. doi:10.1016/j.annemergmed.2019.08.218
   Web of Science ®Google Scholar
• Hernandez-Meier J, Good S, Zosel A. Emergency medicine provider attitudes toward and experiences with prescribing buprenorphine in the ED of a large academic metropolitan hospital. Clin Toxicol. 2019;57(10):1041–1042.
   Web of Science ®Google Scholar
• Lowenstein M, Kilaru A, Perrone J, et al. Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey. Am J Emerg Med. 2019;37(9):1787–1790. doi:10.1016/j.ajem.2019.02.025
   PubMed Web of Science ®Google Scholar
• Martin A, Raja A, White B. Emergency department-initiated medication-assisted treatment: lessons learned one year after launch. Acad Emerg Med. 2019;26:S308.
   Google Scholar
• Medcalf K, McGowan HM, Chu J, Klaiman MZ. Management of acute opioid withdrawal in the emergency department with buprenorphine/naloxone: an assessment of emergency physician knowledge and practice. Canadian J Emerg Med. 2015;17:S20–S21.
   Google Scholar
• Wiercigroch D, Hoyeck P, Sheikh H, Hulme J. Management of opioid withdrawal: A qualitative examination of current practices and barriers to prescribing buprenorphine in a Canadian emergency department. Canadian J Emerg Med. 2019;21:S114.
   Google Scholar
• Lofwall MR, Walsh SL. A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world. J Addict Med. 2014;8(5):315–326. doi:10.1097/ADM.0000000000000045
   PubMed Web of Science ®Google Scholar
• Dasgupta N, Bailey EJ, Cicero T, et al. Post-marketing surveillance of methadone and buprenorphine in the United States. Pain Med. 2010;11(7):1078–1091. doi:10.1111/j.1526-4637.2010.00877.x
   PubMed Web of Science ®Google Scholar
• Jennings LK, Bogan C, McCauley JJ, et al. Rates of substance use disorder treatment seeking visits after emergency department-initiated buprenorphine. Am J Emerg Med. 2020;38(5):975–978. doi:10.1016/j.ajem.2020.02.011
   Web of Science ®Google Scholar
• Andrilla CHA, Moore TE, Patterson DG, Larson EH. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update. J Rural Health. 2019;35(1):108–112. doi:10.1111/jrh.12307
   PubMed Web of Science ®Google Scholar
• Dora-Laskey A, Sadler R. 261 Identifying Barriers to Emergency Department-Initiated Buprenorphine: A Spatial Analysis of Treatment Program Access in Michigan. Ann Emerg Med. 2019;74(4):S102–S103. doi:10.1016/j.annemergmed.2019.08.219
   Web of Science ®Google Scholar